1 haracteristics of IC and non-IC adults using
descriptive statistics.
2 disease staging information were shown using
descriptive statistics.
3 tigen) and all-cause non-S. aureus CAP using
descriptive statistics.
4 n baseline and follow-up was performed using
descriptive statistics.
5 outcomes were analyzed and reported by using
descriptive statistics.
6 etween the groups by use of Kaplan-Meier and
descriptive statistics.
7 days, 60 days, and 90 days before death, by
descriptive statistics.
8 Data were compiled using
descriptive statistics.
9 Data were summarized using nonweighted
descriptive statistics.
10 Safety and tolerability were analysed using
descriptive statistics.
11 The survey data collected were analyzed with
descriptive statistics.
12 The analysis employed
descriptive statistics.
13 ummarized within diagnostic categories using
descriptive statistics.
14 on Questionnaire scores were summarized with
descriptive statistics.
15 d work-up recommendations were analyzed with
descriptive statistics.
16 Results were analyzed by using
descriptive statistics.
17 Close-ended questions were analyzed with
descriptive statistics.
18 Data were summarized by using
descriptive statistics.
19 tistic and by using response frequencies and
descriptive statistics.
20 iotic exposure data were characterized using
descriptive statistics.
21 Adverse events were summarized using
descriptive statistics.
22 17 Classification System, was assessed using
descriptive statistics.
23 All analyses were restricted to
descriptive statistics.
24 Analysis included
descriptive statistics.
25 quartile, and insurance) were analyzed using
descriptive statistics.
26 icipant characteristics were summarized with
descriptive statistics.
27 thologic characteristics were assessed using
descriptive statistics.
28 tics of confirmed cases were summarized with
descriptive statistics.
29 lyze interviews; surveys were analyzed using
descriptive statistics.
30 al signs, and interventions performed, using
descriptive statistics.
31 delines were abstracted and summarized using
descriptive statistics.
32 the trial were extracted and reported using
descriptive statistics.
33 Data were summarised using
descriptive statistics.
34 2015 and March of 2020, were analyzed using
descriptive statistics.
35 graphics of participants were analyzed using
descriptive statistics.
36 ociated ocular injuries were evaluated using
descriptive statistics.
37 se, and adverse events were summarized using
descriptive statistics.
38 We analyzed the results with
descriptive statistics.
39 first diagnosis were reported using standard
descriptive statistics.
40 analysis, and surveys were analyzed by using
descriptive statistics.
41 ome of 7- day mortality was summarized using
descriptive statistics.
42 A combination of
descriptive statistics,
analysis of variance, and t test
43 oups was 1.6 (95% CI 1.4-1.9; p<0.0001) with
descriptive statistics and 1.7 (1.2-2.1; p<0.0001) with
44 Descriptive statistics and 2 x 2 contingency tables were
45 Descriptive statistics and 2-factorial analysis of covar
46 Data were summarized using
descriptive statistics and 95% CIs.
47 Descriptive statistics and 95% confidence intervals (CIs
48 Descriptive statistics and a binary logistic regression
49 Measures were compared using
descriptive statistics and a median regression model, ad
50 Descriptive statistics and a mixed-effects model were us
51 Data analysis involved
descriptive statistics and analysis of change over time
52 Descriptive statistics and areas under the receiver oper
53 We analysed the data using
descriptive statistics and bivariate and multivariate re
54 Descriptive statistics and bivariate correlations were u
55 The results were analyzed by
descriptive statistics and chi-square test.
56 Analyses included
descriptive statistics and chi-square tests.
57 Data were analyzed using
descriptive statistics and chi2 tests to highlight dispa
58 We generated
descriptive statistics and compared pre- and posttreatme
59 Analyses included
descriptive statistics and Cox proportional hazards mode
60 Descriptive statistics and exact 95% confidence interval
61 We analyzed errors/AEs using
descriptive statistics and explored predictors of parent
62 Descriptive statistics and Fisher exact tests were used
63 process and wait times were summarized using
descriptive statistics and fitted to linear mixed regres
64 ) version 9.3 software was used to calculate
descriptive statistics and frequencies.
65 Descriptive statistics and generalized estimating equati
66 tistics; therefore, data were analysed using
descriptive statistics and graphic analysis.
67 Data were analysed with
descriptive statistics and in the intention-to-treat pop
68 Descriptive statistics and intraclass correlation coeffi
69 and selective analysis, will give distorted
descriptive statistics and invalid statistical inference
70 It supports a larger set of
descriptive statistics and is applicable to a wider rang
71 Descriptive statistics and Kaplan-Meier analysis of over
72 Descriptive statistics and Kaplan-Meier analysis was per
73 tcome variables were assessed using standard
descriptive statistics and Kaplan-Meier survival analyse
74 Descriptive statistics and linear [Spearman rank-order (
75 Descriptive statistics and linear multivariate regressio
76 Descriptive statistics and logistic regression analyses
77 Descriptive statistics and logistic regression analyses
78 Descriptive statistics and logistic regression analysis
79 Descriptive statistics and logistic regression models we
80 ARTICIPANTS: This cross-sectional study used
descriptive statistics and logistic regression to analyz
81 Descriptive statistics and logistic regression were used
82 Descriptive statistics and logistic regression were used
83 ime intervals were derived and analyzed with
descriptive statistics and logistic regression.
84 Descriptive statistics and logistic regressions were per
85 Descriptive statistics and MANOVA analysis were used, wi
86 Both
descriptive statistics and Markov-switching models indic
87 or differential protein abundance along with
descriptive statistics and measures of reliability of th
88 Data were analyzed by
descriptive statistics and methods from survival analysi
89 Descriptive statistics and mixed models analyses assesse
90 Analyses included
descriptive statistics and multilevel logistic regressio
91 Descriptive statistics and multinomial logistic regressi
92 Analysis included
descriptive statistics and multiple regression.
93 Descriptive statistics and multivariable linear regressi
94 treatment response and adverse events using
descriptive statistics and multivariable logistic regres
95 ics with and without SPS were compared using
descriptive statistics and multivariable logistic regres
96 Descriptive statistics and multivariable logistic regres
97 Descriptive statistics and multivariable modeling were e
98 We used
descriptive statistics and multivariate analyses, includ
99 Descriptive statistics and multivariate logistic regress
100 Using
descriptive statistics and multivariate logistic regress
101 Descriptive statistics and multivariate logistic regress
102 Data analyses included
descriptive statistics and multivariate random intercept
103 Quantitative analyses included
descriptive statistics and negative binomial regression
104 Descriptive statistics and nonparametric comparisons wer
105 Descriptive statistics and odds ratios (ORs) were used t
106 The data collected were summarised using
descriptive statistics and post-hoc mixed models for rep
107 Data analysis was conducted using
descriptive statistics and presented as frequencies and
108 Descriptive statistics and psychometric properties of th
109 We used
descriptive statistics and regression analyses (controll
110 Descriptive statistics and regression analyses were used
111 Analyses included
descriptive statistics and repeated measures ANOVA/regre
112 for a diverse sample of nations, and employ
descriptive statistics and rigorous panel regression mod
113 Incidence rates of primary shunts,
descriptive statistics and shunt revision rates were cal
114 Statistical analysis consisted of
descriptive statistics and Spearman correlation analysis
115 We used
descriptive statistics and Spearman's correlation coeffi
116 Initial data analyses relied on
descriptive statistics and stratified analyses.
117 Data were analyzed using
descriptive statistics and supplemented with Bayesian or
118 ance was evaluated by kappa coefficient, and
descriptive statistics and t test were used for statisti
119 ge metrics, and interviews, summarised using
descriptive statistics and template analysis.
120 All
descriptive statistics and the percentage of eyes within
121 Analysis included
descriptive statistics and time-to-event analyses estima
122 Data were analyzed using
descriptive statistics and univariate and multivariable
123 Data were analyzed with
descriptive statistics and univariate and multivariable
124 By using
descriptive statistics and weighted linear regression, a
125 Data were analyzed with
descriptive statistics,
and detection performance was an
126 sis, using cDNA microarrays, inferential and
descriptive statistics,
and dynamic mapping of gene expr
127 iatric patient populations, the development,
descriptive statistics,
and test-retest reliability of cr
128 Descriptive statistics are employed.
129 28/50 (56%) required mechanical ventilation.
Descriptive statistics are presented as mean +/- standar
130 Descriptive statistics are presented as medians and inte
131 Descriptive statistics are presented.
132 Baseline results, based on
descriptive statistics are reported.
133 Descriptive statistics as well as unadjusted and risk-ad
134 Descriptive statistics,
binary logistic regression, and
135 Data were analyzed using
descriptive statistics,
bivariate analyses, and multivar
136 s was performed using Stata version 13, with
descriptive statistics,
bivariate analysis using chi-squ
137 Data were analyzed using
descriptive statistics,
bivariate correlation analysis a
138 Descriptive statistics,
bivariate correlation, and logis
139 Analyses included
descriptive statistics,
bivariate correlations, and Stru
140 Stratified,
descriptive statistics by glaucoma status were determine
141 Statistical analysis included
descriptive statistics,
calculation of concordance, McNe
142 Analyses using
descriptive statistics,
chi(2) tests, and logistic regre
143 Descriptive statistics,
chi(2) tests, and logistic regre
144 mly selected older adults and analysed using
descriptive statistics,
chi-square test and logistic reg
145 Data were analyzed by using
descriptive statistics,
Chi-square test, and multivariat
146 Basic
descriptive statistics,
chi-square test, Fisher's exact
147 ography of rod and cone pigment kinetics and
descriptive statistics conducted to highlight difference
148 Descriptive statistics,
correlation analyses, and surviv
149 Descriptive statistics,
correlation analysis, and tests
150 Descriptive statistics,
correlations, and ANOVA were per
151 Descriptive statistics,
correlations, and mixed ANOVAs w
152 have studied these interactions using purely
descriptive statistics (
cross-correlograms or joint peri
153 Results were analysed using
descriptive statistics (
dendrograms and PCA).
154 Descriptive statistics describe utilization/engagement l
155 ata were analyzed using SPSS version 21, and
descriptive statistics,
dispersion indices, tables, and
156 Descriptive statistics (
e.g., means, proportions) were u
157 Descriptive statistics examined patient characteristics.
158 Results were analyzed by
descriptive statistics followed by generalized estimatin
159 We calculated
descriptive statistics for abstracted cases and conducte
160 We calculated
descriptive statistics for all variables.
161 ludes gene summaries for replicate spots and
descriptive statistics for each experiment.
162 All MDEs were evaluated using
descriptive statistics for event type, property damage,
163 Descriptive statistics for outcomes and comparative anal
164 g baseline characteristics were presented by
descriptive statistics for patients with an identified c
165 Data were analyzed using
descriptive statistics for sample characteristics.
166 Descriptive statistics for staging and kappa statistics
167 After calculating
descriptive statistics for the sample, the authors devel
168 uring agonistic interactions; (ii) calculate
descriptive statistics for these behaviors; and (iii) id
169 Together with
descriptive statistics,
for each of the outcome variable
170 Data analysis included
descriptive statistics (
frequencies and percentages), wi
171 Using
descriptive statistics,
generalized estimating, and logi
172 Descriptive statistics,
hypothesis testing, and regressi
173 Descriptive statistics,
incidence rates, Kaplan-Meier su
174 Data analysis was done using Stata and
descriptive statistics including frequency, proportions,
175 Data are presented using
descriptive statistics including relative frequencies, m
176 Descriptive statistics,
including average and standard d
177 DIvol values were created for each year, and
descriptive statistics,
including mean, median, and 75th
178 ge, two observers measured alpha angles, and
descriptive statistics,
including mean, standard deviati
179 Descriptive statistics indicated the sonic brush group h
180 Descriptive statistics,
intraclass correlation coefficie
181 Descriptive statistics,
intraclass correlation coefficie
182 Using spatial
descriptive statistics it was found that the drug was ra
183 Item
descriptive statistics,
item convergent and discriminant
184 Descriptive statistics,
Kaplan-Meier survival curves and
185 Descriptive statistics,
linear mixed-effects models, and
186 Descriptive statistics,
logistic and linear regressions,
187 of total ICU charges and analyzed by simple
descriptive statistics (
mean +/- sd).
188 Outcomes were presented as raw data and
descriptive statistics (
means +/- standard deviations).
189 Descriptive statistics (
means, medians, standard deviati
190 Following preliminary
descriptive statistics,
multiple logistic and linear reg
191 We performed
descriptive statistics,
multivariate logistic regression
192 tained were tested statistically by means of
descriptive statistics,
non-paired t-test, Mann-Whitney
193 Statistical analyses included
descriptive statistics,
normality test, and a multicompa
194 Data were analyzed using
descriptive statistics of all variables.
195 We show that
descriptive statistics of distance distribution, such as
196 of possible substitution patterns and simple
descriptive statistics of the distribution are thus obta
197 In this Article, we present
descriptive statistics on PCMC in four settings across t
198 Here, we present
descriptive statistics on several key domains of assessm
199 Descriptive statistics outlined the frequency of venous
200 Descriptive statistics,
paired and multiple group compar
201 ikelihood approaches and were compared using
descriptive statistics,
Pearson correlation coefficients
202 racterization using optical flow estimation,
descriptive statistics,
principal component, and indepen
203 The
descriptive statistics proposed include the fraction of
204 Additionally,
descriptive statistics regarding the number of Operation
205 ability of these MR imaging measurements and
descriptive statistics representative of the general pop
206 hroughout the entire 6-month healing period,
descriptive statistics revealed no significant time or g
207 Descriptive statistics revealed that 590 (37%) participa
208 The analysis includes
descriptive statistics,
risk attribution, and multivaria
209 ry outcome of mortality was summarized using
descriptive statistics;
secondary outcome was, risks for
210 Descriptive statistics show that LD decays much faster i
211 Descriptive statistics,
significance tests, Cronbach's a
212 Descriptive statistics,
simple correlation, and stepwise
213 Descriptive statistics,
Spearman correlation coefficient
214 Descriptive statistics,
Spearman correlation, analysis o
215 ting with various symptoms was analysed with
descriptive statistics,
stratified by mutation type.
216 Descriptive statistics,
such as frequencies, means, SDs,
217 Descriptive statistics summarised the sample and survey
218 Descriptive statistics summarized principal findings, an
219 We used
descriptive statistics,
survival analysis, and pooled lo
220 Descriptive statistics,
t tests, and regression analyses
221 Descriptive statistics,
t tests, and regression analyses
222 Descriptive statistics,
t-tests, one-way analysis of var
223 tion is "regular," they should be treated as
descriptive statistics that convey variation in the fact
224 This article proposes several
descriptive statistics that quantify the extent and patt
225 er delayed radical prostatectomy (RP), using
descriptive statistics,
the Kaplan-Meier method, and mul
226 Data were analyzed using
descriptive statistics,
the Mann-Whitney test, the Krusk
227 keratinized tissue (KT) were analyzed using
descriptive statistics,
the paired t test, McNemar test,
228 Analyses consisted of
descriptive statistics,
time series plots, and simple li
229 We ranked all countries and used
descriptive statistics to analyse global trends.
230 We used
descriptive statistics to analyse the data collected dur
231 We used
descriptive statistics to assess whether the prevalence
232 We used
descriptive statistics to calculate how many quality mea
233 All variables were analyzed using
descriptive statistics to calculate means, SDs, and freq
234 Analyses included
descriptive statistics to characterize measurement chara
235 We used
descriptive statistics to describe trends in drug shorta
236 Pearson product moment correlation (r ) and
descriptive statistics to evaluate retrospectively the r
237 We used
descriptive statistics to examine reasons for cannabis u
238 edicted FVC and 6-min walking distance, with
descriptive statistics to week 76 and with random-interc
239 Using
descriptive statistics,
trend tests and spatial prioriti
240 Descriptive statistics,
univariate and multivariable Cox
241 Descriptive statistics,
univariate and multivariate mixe
242 Descriptive statistics,
univariate correlations, and ste
243 Descriptive statistics was used for statistical analysis
244 In addition to basic
descriptive statistics,
we estimated Poisson regression
245 t baseline and 1-year follow-up, we compared
descriptive statistics,
weight status prevalence, and BI
246 Descriptive statistics were calculated for APE, HUL, and
247 Descriptive statistics were calculated for cases and con
248 ost prevalent diagnoses were determined, and
descriptive statistics were calculated for demographics
249 Descriptive statistics were calculated for the total sam
250 Descriptive statistics were calculated to describe ratin
251 Descriptive statistics were calculated, and median confi
252 Descriptive statistics were calculated, followed by biva
253 c and surgical variables were collected, and
descriptive statistics were calculated.
254 Summary
descriptive statistics were calculated.
255 Descriptive statistics were calculated.
256 Descriptive statistics were compiled for the subsample o
257 Descriptive statistics were completed along with multiva
258 Descriptive statistics were computed for all factors.
259 Descriptive statistics were computed for all variables.
260 Descriptive statistics were computed, and a one-way rand
261 Survey data were analyzed and
descriptive statistics were determined.
262 Descriptive statistics were expressed as mean +/- SD.
263 By using statistics software,
descriptive statistics were generated with 95% confidenc
264 Descriptive statistics were generated, and 95% confidenc
265 Descriptive statistics were generated.
266 eatment, and outcome data were collected and
descriptive statistics were performed on variables of in
267 Data were stratified by race,
descriptive statistics were performed, and time series w
268 Descriptive statistics were performed.
269 Descriptive statistics were presented as means or freque
270 Descriptive statistics were the following: core, x = 37.
271 Descriptive statistics were used (means, standard deviat
272 Descriptive statistics were used for comparison to NHANE
273 Descriptive statistics were used for continuous variable
274 Descriptive statistics were used for individual items, a
275 Descriptive statistics were used to analyse results, wit
276 Descriptive statistics were used to analyze categorical
277 Descriptive statistics were used to analyze dose indexes
278 Descriptive statistics were used to assess the public's
279 Descriptive statistics were used to characterize the pat
280 Descriptive statistics were used to characterize the pat
281 Descriptive statistics were used to characterize the stu
282 Descriptive statistics were used to compare online PEMs
283 aplan-Meier estimates of median survival and
descriptive statistics were used to compare patient and
284 Descriptive statistics were used to define patient chara
285 CPR than men when they collapse in public?"
Descriptive statistics were used to define the cohort.
286 Simple
descriptive statistics were used to describe cohort char
287 Descriptive statistics were used to describe the socio-d
288 fficient, coefficient of variation (CV), and
descriptive statistics were used to determine the levels
289 Descriptive statistics were used to evaluate agreement a
290 Descriptive statistics were used to report different rat
291 Descriptive statistics were used to summarise the data.
292 Descriptive statistics were used to summarize baseline p
293 Descriptive statistics were used to summarize mutation a
294 Descriptive statistics were used to summarize sleep/wake
295 Descriptive statistics were used to summarize the data.
296 Descriptive statistics were used to summarize the popula
297 Descriptive statistics were used to summarize the result
298 Descriptive statistics were used.
299 The metabolomic profiles were compared using
descriptive statistics which indicated that key primary
300 eline and outcome data were summarized using
descriptive statistics,
with continuous variables report